Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+75.2%
5Y CAGR+44.6%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+75.2%/yr
vs -25.4%/yr prior
5Y CAGR
+44.6%/yr
Recent acceleration
Acceleration
+100.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $3.68M | +76.0% |
| 2024 | $2.09M | -7.9% |
| 2023 | $2.27M | +232.2% |
| 2022 | $684000.00 | +1355.3% |
| 2021 | $47000.00 | -91.9% |
| 2020 | $582000.00 | -77.0% |
| 2019 | $2.53M | +14.9% |
| 2018 | $2.20M | +147.0% |
| 2017 | $892000.00 | +104.1% |
| 2016 | $437000.00 | - |